![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/08/2909602/0/en/Biora-Therapeutics-to-Host-Virtual-KOL-Event-on-NaviCap-Targeted-Oral-Delivery-Platform-and-Results-from-Phase-1-Clinical-Trial-of-BT-600-on-July-17-2024.html
https://www.globenewswire.com/news-release/2024/07/01/2906658/0/en/Biora-Therapeutics-Announces-Positive-Clinical-Trial-Results-for-BT-600.html
https://www.globenewswire.com/news-release/2024/06/11/2896711/0/en/Biora-Therapeutics-Announces-Presentation-on-the-BioJet-Systemic-Oral-Delivery-Platform-at-the-Next-Gen-Peptide-Formulation-Delivery-Summit-2024.html
https://www.globenewswire.com/news-release/2024/05/20/2884813/0/en/Biora-Therapeutics-Presents-Clinical-Data-on-Device-Function-of-the-NaviCap-Platform-at-Digestive-Disease-Week-2024.html
https://www.globenewswire.com/news-release/2024/05/15/2882870/0/en/Biora-Therapeutics-Provides-Corporate-Update-and-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/07/2876650/0/en/Biora-Therapeutics-to-Report-First-Quarter-2024-Financial-Results-and-Provide-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/06/2875754/0/en/Biora-Therapeutics-to-Present-Clinical-Data-on-Device-Function-of-the-NaviCap-Oral-Delivery-Platform-at-Digestive-Disease-Week-2024.html
https://www.globenewswire.com/news-release/2024/04/30/2872202/0/en/Biora-Therapeutics-Announces-Completion-of-Multiple-Ascending-Dose-MAD-Cohorts-for-Clinical-Trial-of-BT-600.html
https://www.globenewswire.com/news-release/2024/04/08/2859129/0/en/Biora-Therapeutics-Announces-New-Patent-Covering-its-BioJet-Liquid-Jet-Delivery-Technology.html
https://www.globenewswire.com/news-release/2024/04/04/2857705/0/en/Biora-Therapeutics-Achieves-Positive-Interim-Results-for-Clinical-Trial-of-BT-600-Advancing-NaviCap-Platform-Development.html